astmedАстраханский медицинский журналAstrakhan medical journal1992-6499ФГБОУ ВО Астраханский ГМУ Минздрава России10.29039/1992-6499-2023-2-110-119astmed-278Research ArticleНАБЛЮДЕНИЯ ИЗ ПРАКТИКИOBSERVATIONS FROM PRACTICEО трудностях диагностики и осложнениях опухоли КлацкинаAbout the difficuties of the diagnostics and treament of the Klatskin`s tumourДедовА. В.DedovA. V.

А.В. Дедов, кандидат медицинских наук, доцент, доцент кафедры пропедевтики внутренних болезней

Астрахань

A.V. Dedov, Cand. Sci (Med.), Associate Professor, Associate Professor of Department

Astrakhan

dedov1965.d@yandex.ruМустафинР. Д.MustafinR. D.

Р.Д. Мустафин, доктор медицинских наук, профессор, заведующий кафедрой госпитальной хирургии

Астрахань

R.D. Mustafin, Dr. Sci (Med.), Professor, Head of the Department

Astrakhan

robert-mustafin1@yandex.ruПолухинаЕ. А.PolukhinaE. A.

Е.А. Полухина, студентка III курса лечебного факультета

Астрахань

E.A. Polukhina, 3rd year student of the Faculty of Medicine

Astrakhan

katena-polukhina@mail.ruАстраханский государственный медицинский университетРоссияAstrakhan State Medical UniversityRussian Federation202318072023182110–119Copyright © Дедов А.В., Мустафин Р.Д., Полухина Е.А., 20232023Дедов А.В., Мустафин Р.Д., Полухина Е.А.Dedov A.V., Mustafin R.D., Polukhina E.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.astmedj.ru/jour/article/view/278

Актуальность темы обусловлена недостаточной информированностью врачей об опухоли Клацкина (воротной холангиокарциноме). Это связано с весьма редкой встречаемостью заболевания и слабой ознакомленностью практических врачей, особенно терапевтов, с клиническими проявлениями, современными возможностями дифференциальной диагностики и методами лечения данной патологии. Описан клинический случай воротной холангиокарциномы у мужчины 66 лет, рассмотрены трудности при установлении окончательного диагноза. Отражены особенности современных лабораторно-инструментальных методов медицинской визуализации и технологии интервенционных вмешательств и химиотерапии. Представлен клинический случай указанного заболевания.

The relevance of the topic is caused by the insufficient acquaintance of Klatskin's tumor, or the portal cholangiocarcinoma, among the general practitioners, because of the evident rarity of the disease and poor information available for the practical doctors, especially internists, upon the modern opportunities of its clinical manifestations, differential diagnosis and methods of treatment of this pathology. Clinical observation of the portal cholangiocarcinoma at the man of 66 years old is described from the moment of the first complaints/ The difficulties at establishment of the final diagnosis, with the description of modern laboratory toolinstrumental methods of medical visualization, the technics of medical interventions and chemotherapy are represented. A clinical case of this disease is presented.

холангиоцеллюлярная карциномаопухоль Клацкинадиагностикамедицинская визуализациялечениеосложненияпрогнозcholangiocellular carcinomaKlatskin's tumordiagnosismedical visualizationtreatmentcomplica-tionsprognosisReferencesEverhart J. E. and Ruhl C. E. Burden of digestive diseases in the United States part III : liver, biliary tract, and pancreas // Gastroenterology. 2009. Vol. 136, no. 4. P. 1134–1144.Everhart J. E., and Ruhl C. E. Burden of digestive diseases in the United States part III: liver, biliary tract, and pancreas. Gastroenterology. 2009; 136 (4): 1134-1144.Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tu-mor with distinctive clinical and pathological features // The American Journal of Medicine. 1965. Vol. 38, no. 2. P. 241–256.Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tu-mor with distinctive clinical and pathological features. The American Journal of Medicine. 1965; 38 (2): 241-256.Прохоров А. В., Папок В. Е. Опухоль Клатскина : учебно-методическое пособие. Минск : БГМУ, 2015. 16 сProhorov A. V., Papok V. E. Tumor Klatskin: teaching aid. Minsk: Belarusian State Medical University; 2015. 16 p. (In Russ.).Bergquist A., von Seth E. Epidemiology of cholangiocarcinoma // Best Practice & Research Clinical Gastro-enterology. 2015. Vol. 29, no. 2. P. 221–232.Bergquist A., von Seth E. Epidemiology of cholangiocarcinoma. Best Practice & Research Clinical Gastroen-terology. 2015; 29 (2): 221-232.Khan S. A., Davidson B. R., Goldin R. D., Heaton N., Karani J., Pereira S. P., Rosenberg W. M., Tait P., Tay-lor-Robinson S. D., Thillainayagam A. V., Thomas H. C., Wasan H. British Society of Gastroenterology. Guidelines for the diagnosis and treatment of cholangiocarcinoma : an update // Gut. 2012. Vol. 61, no. 12. P. 1657–1669.Khan S. A., Davidson B. R., Goldin R. D., Heaton N., Karani J., Pereira S. P., Rosenberg W. M., Tait P., Tay-lor-Robinson S. D., Thillainayagam A. V., Thomas H. C., Wasan H. British Society of Gastroenterology. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut. 2012; 61 (12): 1657-1669.Valle J. W., Borbath I., Khan S. A., Huguet F., Gruenberger T., Arnold D.; ESMO Guidelines Committee. Bili-ary cancer : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up // Annals of Oncology. 2016. Vol. 27, no. 5. P. 28–37.Valle J. W., Borbath I., Khan S. A., Huguet F., Gruenberger T., Arnold D.; ESMO Guidelines Committee. Bili-ary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2016; 27 (5): 28-37.Associazione Italiana di Oncologia Medica. I Dati regionali. I Numeri del cancro in Italia 2018. Versione per pazienti e cittadini a cura di Fondazione AIOM. Via Malta 12/B – 25124 Brescia. Istituto Superiore di Sanitа. URL: https://www.aiom.it/wp content/uploads/2018/10/2018NumeriCancro-operatori.pdf.Associazione Italiana di Oncologia Medica. I Dati regionali. I Numeri del cancro in Italia 2018. Versione per pazienti e cittadini a cura di Fondazione AIOM. Via Malta 12/B – 25124 Brescia. Istituto Superiore di Sanitа. URL: https://www.aiom.it/wp content/uploads/2018/10/2018NumeriCancro-operatori.pdf.Khan S. A., Emadossadaty S., and Ladep N. G. Rising trends in cholangiocarcinoma : is the ICD classifica-tion system misleading us // Journal of Hepatology. 2012. Vol. 56, no. 4. P. 848–854.Khan S. A., Emadossadaty S., and Ladep N. G. Rising trends in cholangiocarcinoma: is the ICD classifica-tion system misleading us. Journal of Hepatology. 2012; 56 (4): 848-854.European Association for the Study of the Liver. EASL Clinical Practice Guidelines : management of cho-lestatic liver diseases // Journal of Hepatology. 2009. Vol. 51, no. 2. P. 237–267.European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of choles-tatic liver diseases. Journal of Hepatology. 2009; 51 (2): 237-267.Sierra H., Cordova M., Chen C. J., Rajadhyaksha M. Confocal imaging-guided laser ablation of basal cell carcinomas : an ex vivo study //Journal of Investigative Dermatology. 2015. Vol. 135, no. 2. P. 612–615.Sierra H., Cordova M., Chen C. J., Rajadhyaksha M. Confocal imaging-guided laser ablation of basal cell carcinomas: an ex vivo study. Journal of Investigative Dermatology. 2015; 135 (2): 612-615.11Сторожаков Г. И., Федоров И. Г., Чичкина М. А., Косюра С. Д., Ильченко Л. Ю. Случай неспецифического язвенного колита, осложненного развитием рака толстой кишки и опухоли Клацкина // Доказательная гастроэнтерология. 2014. Т. 3, № 1. C. 38–42.Storozhakov G. I., Fedorov I. G., Chichkina M. A., Kosjura S. D., Il'chenko L. Ju. A case of nonspecific ul-cerative colitis complicated by the development of colon cancer and Klatskin's tumor. Dokazatel'naya gastroenter-ologiya = Russian Journal of Evidence-Based Gastroenterology. 2014; 3 (1): 38-42. (In Russ.).Patel A. H., Harnois D. M., Klee G. G., LaRusso N. F., Gores G. J. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing сholangitis // American Journal of Gastroenterology. 2000. Vol. 95, no. 1. P. 204–207.Patel A. H., Harnois D. M., Klee G. G., LaRusso N. F., Gores G. J. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing сholangitis. American Journal of Gastroenterology. 2000; 95 (1): 204-207.Levy C., Lymp J., Angulo P., Gores G. J., Larusso N., Lindor K. D. The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis // Digestive Diseases and Sciences. 2005. Vol. 50, no. 9. P. 1734–1740.Levy C., Lymp J., Angulo P., Gores G. J., Larusso N., Lindor K. D. The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis. Digestive Diseases and Sciences. 2005; 50 (9):Sinakos E., Saenger A. K., Keach J., Kim W. R., Lindor K. D. Many patients with primary sclerosing cholan-gitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma // Clinical Gastroenter-ology and Hepatology. 2011. Vol. 9, no. 5. P. 434–439.-1740.Masselli G., Manfredi R., Vecchioli A., Gualdi G. MR imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma : correlation with surgical and pathologic findings // European Journal of Radiology. 2008. Vol. 18, no. 10. P. 2213–2221.Sinakos E., Saenger A. K., Keach J., Kim W. R., Lindor K. D. Many patients with primary sclerosing cholan-gitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma. Clinical Gastroenterology and Hepatology. 2011; 9(5): p. 434-439.Moon C. M., Bang S., Chung J. B., Seung W. P., Si Y. S., Mijin Y., Jong D. L. Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas // Journal of Gastroenterology and Hepatology. 2008. Vol. 23, no. 5. P. 759–765.Masselli G., Manfredi R., Vecchioli A., Gualdi G. MR imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma: correlation with surgical and pathologic findings. European Journal of Radiology. 2008; 18(10): 2213-2221.Lee J., Park S. H., Chang H. M. , Kim J. S., Choi H. J., Lee M. A., Jang J. S., Jeung H. C., Kang J. H., Lee H. W., Shin D. B., Kang H. J., Sun J.-M., Park J. O., Park Y. S., Kang W. K., Lim H. Y. Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer : a multicentre, open-label, randomised, phase 3 study // The Lancet Oncology. 2012. Vol 13, no. 2. P. 181–188.Moon C. M., Bang S., Chung J. B., Seung W. P., Si Y. S., Mijin Y., Jong D. L. Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas. Jour-nal of Gastroenterology and Hepatology. 2008; 23 (5): 759-765.Boehm L. M., Jayakrishnan T. T., Miura J. T., Zacharias A. J., Johnston F. M., Turaga K. K., Gamblin T. C. Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma // Journal of Surgical Oncology. 2015. Vol. 111, no. 2. P. 213–220.Lee J., Park S. H., Chang H. M., Kim J. S., Choi H. J., Lee M. A., Jang J. S., Jeung H. C., Kang J. H., Lee H. W., Shin D. B., Kang H. J., Sun J.-M., Park J. O., Park Y. S., Kang W. K., Lim H. Y. Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study. The Lancet Oncology. 2012; 13 (2): 181-188.Ajith K. Siriwardena. Klatskin Tumor // Journal of Clinical Oncology. 2017. Vol. 35, no. 36. P. 4091–4092.Boehm L. M., Jayakrishnan T. T., Miura J. T., Zacharias A. J., Johnston F. M., Turaga K. K., Gamblin T. C. Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma. Journal of Surgical Oncology. 2015; 111 (2): 213-220.Desai H., Gondalia R., Suhocki P. Percutaneous Hepaticojejunostomy across an Isolated Bile Duct after Klatskin Tumor Resection // Journal of Vascular and Interventional Radiology. 2019. Vol. 30, no. 8. P. 1242–1243.Ajith K. Siriwardena. Klatskin Tumor. Journal of Clinical Oncology. 2017; 35 (36): 4091-4092.Козлов А. В., Таразов П. Г., Поликарпов А. А., Моисеенко А. В., Урбанский А. И., Юткин М. В., Якшиева Г. М., Гранов Д. А. Антеградная эндобилиарная щипцовая биопсия улучшает диагностику опухоли Клацкина по сравнению с браш-биопсией // Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2022. Т. 32, № 2. C. 45–54.Desai H., Gondalia R., Suhocki P. Percutaneous Hepaticojejunostomy across an Isolated Bile Duct after Klatskin Tumor Resection. Journal of Vascular and Interventional Radiology. 2019; 30 (8): 1242-1243.Endo I., Gonen M., Yopp A. C., Dalal K. M., Zhou Q., Klimstra D., D'Angelica M., DeMatteo R. P., Fong Y., Schwartz L., Kemeny N., O'Reilly E., Abou-Alfa G. K., Shimada H., Blumgart L. H., Jarnagin W. R. Intrahepatic chol-angiocarcinoma : rising frequency, improved survival, and determinants of outcome after resection // Annals of Sur-gery. 2008. Vol. 248, no. 1. P. 84–96.Kozlov A. V., Tarazov P. G., Polikarpov A. A., Moiseenko A. V., Urbanskij A. I., Jutkin M. V., Jakshieva G. M., Granov D. A. Antegrade endobiliary forceps biopsy improves diagnosis of Klatskin tumor compared to brush biop-sy. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii = Russian Journal of Gastroenterology, Hepatolo-gy, Coloproctology. 2022; 32 (2): 45-54. (In Russ.).Cambridge W. A., Fairfield C., Powell J. J., Harrison E. M., Søreide K., Wigmore S. J., Guest R. V. Meta-analysis and Meta-regression of Survival After Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma. // Annals of Surgery. 2021. Vol. 273, no. 2. P. 240–250.Endo I., Gonen M., Yopp A. C., Dalal K. M., Zhou Q., Klimstra D., D'Angelica M., DeMatteo R. P., Fong Y., Schwartz L., Kemeny N., O'Reilly E., Abou-Alfa G. K., Shimada H., Blumgart L. H., Jarnagin W. R. Intrahepatic chol-angiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Annals of Surgery. 2008; 248 (1): 84-96.Cambridge W. A., Fairfield C., Powell J. J., Harrison E. M., Søreide K., Wigmore S. J., Guest R. V. Meta-analysis and Meta-regression of Survival After Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma. Annals of Surgery: 2021; 273 (2): 240-250.Cambridge W. A., Fairfield C., Powell J. J., Harrison E. M., Søreide K., Wigmore S. J., Guest R. V. Meta-analysis and Meta-regression of Survival After Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma. Annals of Surgery: 2021; 273 (2): 240-250.

The authors declare that there are no conflicts of interest present.